Why Life Sciences Leaders Are Reassessing Their Cloud Strategies

June 2, 2026

Gilead to invest $100 million in Assembly Bio in return for all current and future programs

October 19, 2023

Dermata’s DMT310 Phase 2 clinical trial for rosacea treatment crashes but shows promising acne treatment results

December 13, 2022

Must Read

The Future of Global Drug Regulation

August 24, 2026

Why Pharmaceutical Companies Need AI Factories

August 24, 2026

Phase 3 of Merck and Moderna’s customized cancer vaccine lowers recurrence, paving the way for approval

August 21, 2026

About Us

Life Sciences Voice is the leading resource for life sciences executives to get crucial insights, explore the latest innovations, and learn about industry trends. Life Sciences Voice provides the community with thought-provoking commentary in multiple formats covering a range of issues from drug discovery to commercial success.

Novo Launches Late-Stage Trial of Lower-Dose Wegovy Pill for Weight Management

Oregon Study Finds Triple-Drug Regimen Kept Infant Macaques HIV-Free for One Year

Summit and Akeso Report Updated HARMONi Survival Data for Ivonescimab in Western NSCLC Patients

ARPA-H Awards Up to $160 Million for Personalized Genetic Medicine Development

Biokin’s Iza-Bren Meets Primary Endpoint in Phase 3 Panku-Lung01 Lung Cancer Trial

Definium Bags Major Phase 3 Victory With LSD Formula

Taiho and Cullinan Report Phase 3 Progression-Free Survival Win for Zipalertinib

MoonLake Reports Positive Phase 3 Results for Sonelokimab in Psoriatic Arthritis

Leo Pharma Pens Mega Deal to Buy Tanabe’s Skin Disease Drug

PTC Therapeutics Acquires ST-920 Fabry Disease Gene Therapy Program From Sangamo

Zealand Bags Huge Money By Selling Rights to Takeda’s Blood Cancer Drug

Claryx Appears From Stealth to Deal with the $45B Hospital-Acquired Infections Issue

J&J’s OTTAV Robotic Surgical System has received FDA market authorization in the U.S.

Alnylam Inks $2B Agreement With Inceptive to Change sIRNA Design With AI Leader

Chugai and Gero Partner to Develop Antibodies for Age-Related Diseases Using AI

The Future of Global Drug Regulation

Why Pharmaceutical Companies Need AI Factories

Quantum Computing and Drug Discovery

Why Data Is Becoming Pharma’s Most Valuable Asset

Tag: Global Drug Regulation

The Future of Global Drug Regulation

Editor Picks

Why Life Sciences Leaders Are Reassessing Their Cloud Strategies

Gilead to invest $100 million in Assembly Bio in return for all current and future programs

Dermata’s DMT310 Phase 2 clinical trial for rosacea treatment crashes but shows promising acne treatment results

Must Read

The Future of Global Drug Regulation

Why Pharmaceutical Companies Need AI Factories

Phase 3 of Merck and Moderna’s customized cancer vaccine lowers recurrence, paving the way for approval

Hot Topics

About Us

Follow Us